Medical Devices News

LONDON--(BUSINESS WIRE)--C2N Diagnostics, LLC ("C2N"), a pioneer in advanced diagnostic testing for brain health, and Cambridge Cognition, the neuroscience technology company, announce on World Alzheimer’s Day a partnership with The Alzheimer's Trust, a newly formed subsidiary of The Cancer Screening Trust, to address the urgent and growing burden of Alzheimer's disease and related dementias in the United Kingdom (UK).The collaboration creates an integrated, scalable pathway for earlier and more...

SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics, today announced that it will host a virtual presentation on Wednesday, September 23, 2026, at 4:30 p.m. ET. The presentation will provide an overview of the ARCT-810 Phase 2 clinical program for Ornithine transcarbamylase (OTC) deficiency and Arcturus’ mRNA liver therapeutics pl...

RUTHERFORD, N.J. & LA JOLLA, Calif.--(BUSINESS WIRE)--Lōkahi Therapeutics™ renews its University of Alabama collaboration, advancing real-world asset evaluation and developing key future biopharma talent....

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at Bernstein Insights: Healthcare Leaders and Disruptors – 3rd Annual Healthcare Forum on Thursday, September 24, 2026, at 12:30 p.m. (Eastern Time). The live webcast and replay of the presentation will be accessible on the Insulet Investor Relations website: investors.insulet.com/events. About...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced that the U.S. Food and Drug Administration’s (FDA) Cosmetics Regulatory Science Branch has licensed ADMET Predictor® to support its computational research for modern cosmetic safety assessment. The contract expands the use of Simulations Plus technology...

MESA, Ariz.--(BUSINESS WIRE)--Fusion Orthopedics USA, LLC (“Fusion Orthopedics”) today announced the upcoming launch of its FibFix™ Fibula Nail System, a next-generation intramedullary nail solution designed specifically for the treatment of distal fibula fractures. Fusion Orthopedics will introduce the FibFix Fibula Nail System to the orthopedic community at the American Orthopaedic Foot & Ankle Society (AOFAS) Annual Meeting & IFFAS 9th Biennial Meeting, September 16–19, 2026, at the...

ALAMEDA, Calif.--(BUSINESS WIRE)--Science Corporation, the neural engineering and brain-computer interface company, today announced the appointment of its Chief Strategy Officer, Darius Shahida, as President, effective immediately. Shahida will continue in his responsibilities leading the company’s work with investors, global commercialization, and partnership efforts and will continue to report to the CEO and co-founder, Max Hodak.“In many ways, our company is entering a new commercial era. Dar...

TORONTO--(BUSINESS WIRE)--Everest Clinical Research (“Everest”), a data-first, full-service clinical research organization, today announced the acquisition of the Biometrics and Data Services business unit of Firma Clinical Research (“Firma DS”), expanding Everest's global biometrics expertise and clinical data science capabilities. Everest is a portfolio company of Arlington Capital Partners (“Arlington”), a Washington, D.C.-area private equity firm with extensive experience investing in regul...

WESTON, Mass.--(BUSINESS WIRE)--Medical technology company Sempresto, developing a smartphone-integrated drug delivery platform designed to make rescue medications more readily available when needed, today announced a positive response to its Type B Pre-Investigational New Drug (Pre-IND) written submission to the U.S. Food and Drug Administration (FDA) regarding its investigational smartphone-integrated epinephrine auto-injector. Sempresto submitted a comprehensive briefing package containing a...

KIRKLAND, Wash.--(BUSINESS WIRE)--CurvaFix, Inc. will sponsor an industry session at the 42nd Annual Orthopaedic Trauma Association Meeting (OTA), Sept. 23-26 at the Music City Center in Nashville, where orthopedic trauma surgeons will present real-world performance data from the first 3,800 CurvaFix implants and review recently published clinical experience with the technology. The company will also exhibit at Booth #222.Across the first 3,800 CurvaFix implants, placed by more than 200 surgeons...